MDT Q2 2022 Earnings — Medtronic plc Revenue & Financial Results | Market Cap Arena

MDTMedtronic plc

$114B

Q2 2022 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$7.8B+2.6% YoY

Gross Profit

$5.3B68.2% margin

Operating Income

$1.6B19.9% margin

Net Income

$1.3B16.7% margin

EPS (Diluted)

$0.97

QoQ Revenue Growth

-1.8%

Cash Flow

Operating Cash Flow

$1.8B

Free Cash Flow

$1.5B

Stock-Based Comp.

$140M

Balance Sheet

Total Assets

$91.8B

Total Liabilities

$39.6B

Stockholders' Equity

$52.0B

Cash & Equivalents

$2.9B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$7.8B	$7.6B	+2.6%
Gross Profit	$5.3B	$4.9B	+8.3%
Operating Income	$1.6B	$930M	+68.1%
Net Income	$1.3B	$489M	+168.1%

Revenue Segments

Cardiac and Vascular Group

$2.8B36%

Medical Surgical

$2.3B29%

Neuroscience Group

$2.1B27%

Diabetes Group

$585M7%

Geographic Segments

UNITED STATES

$4.0B51%

Total Other Countries, Excluding United States and Ireland

$3.8B49%

IRELAND

$27M0%